Fairchem Organic's Q3 financials show decline in profits and efficiency, 'Strong Sell' call by MarketsMOJO

Nov 16 2024 04:47 PM IST
share
Share Via
Fairchem Organic, a smallcap chemicals company, reported a negative performance in the quarter ending September 2024 with a score of -10. However, the company has shown consistent growth in operating cash flow over the last three years, but profit before tax and net sales have seen a decline. MarketsMojo has given a 'Strong Sell' call for the company's stock.

Fairchem Organic, a smallcap company in the chemicals industry, recently announced its financial results for the quarter ending September 2024. According to the data, the company has seen a negative performance in the quarter, with a score of -10 compared to 18 in the previous quarter.

Despite this, there are some positive aspects to the company's financials. Fairchem Organic has shown a consistent growth in its operating cash flow over the last three years, with the highest amount of Rs 74.48 crore in the last year. This indicates that the company has been able to generate higher cash revenues from its business operations.

However, there are also some concerning factors in the financials. The company's profit before tax (PBT) has fallen by 68% compared to the average of the previous four quarters, and the profit after tax (PAT) has also seen a decline of 66.7%. Additionally, the net sales for the quarter have fallen by 11.4% compared to the average of the previous four quarters, and the operating profit (PBDIT) is at its lowest in the last five quarters.

The company's operating profit margin has also decreased, indicating a decline in efficiency. Furthermore, the earnings per share (EPS) for the quarter are at its lowest in the last five quarters, showing a decline in profitability and lower earnings for shareholders.

Based on these financials, MarketsMOJO has given a 'Strong Sell' call for Fairchem Organic's stock. It is important for investors to carefully consider these factors before making any investment decisions.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News